Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Journal of Cancer Research and Clinical Oncology
|
May 23, 2023
Correction: Mitochondrial dysfunction and drug targets in multiple myeloma
Yushan Cui, Fujue Wang, Baijun Fang
Journal of Cancer Research and Clinical Oncology
|
March 17, 2023
Mitochondrial dysfunction and drug targets in multiple myeloma
Yushan Cui, Fujue Wang, Baijun Fang
Leukemia Research Reports
|
May 31, 2022
Microtransplantation for myeloid sarcoma: Two case reports
Xue Zhang, Shuoting Wang, Fujue Wang, et al.
Journal of Cancer
|
May 6, 2020
Aberrant LncRNA Expression in Leukemia
Jie Gao, Fujue Wang, Pengqiang Wu, et al.
Clinical and Experimental Medicine
|
March 19, 2026
Investigation of the expression and potential mechanistic role of BYSL in acute myeloid leukemia
Jie Gao, Fujue Wang, Yingying Chen, et al.
Oncotarget
|
November 5, 2017
Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4
Tao Jiang, Fujue Wang, Lianjie Hu, et al.
Oncotarget
|
May 17, 2018
Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4
Tao Jiang, Fujue Wang, Lianjie Hu, et al.
American Journal of Translational Research
|
April 8, 2024
Erratum: CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway
Zhengchang He, Shaoxian Shen, Yuyao Yi, et al.
Journal of Orthopaedic Surgery and Research
|
May 25, 2023
CPEB2 enhances cell growth and angiogenesis by upregulating ARPC5 mRNA stability in multiple myeloma
Piaorong Zeng, Fujue Wang, Xingxing Long, et al.
Frontiers in Pharmacology
|
February 8, 2024
Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)
Yiwen Bao, Jiaju Chen, Luting Duan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Journal of Cancer Research and Clinical Oncology
|
May 23, 2023
Correction: Mitochondrial dysfunction and drug targets in multiple myeloma
Yushan Cui, Fujue Wang, Baijun Fang
Journal of Cancer Research and Clinical Oncology
|
March 17, 2023
Mitochondrial dysfunction and drug targets in multiple myeloma
Yushan Cui, Fujue Wang, Baijun Fang
Leukemia Research Reports
|
May 31, 2022
Microtransplantation for myeloid sarcoma: Two case reports
Xue Zhang, Shuoting Wang, Fujue Wang, et al.
Journal of Cancer
|
May 6, 2020
Aberrant LncRNA Expression in Leukemia
Jie Gao, Fujue Wang, Pengqiang Wu, et al.
Clinical and Experimental Medicine
|
March 19, 2026
Investigation of the expression and potential mechanistic role of BYSL in acute myeloid leukemia
Jie Gao, Fujue Wang, Yingying Chen, et al.
Oncotarget
|
November 5, 2017
Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4
Tao Jiang, Fujue Wang, Lianjie Hu, et al.
Oncotarget
|
May 17, 2018
Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4
Tao Jiang, Fujue Wang, Lianjie Hu, et al.
American Journal of Translational Research
|
April 8, 2024
Erratum: CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway
Zhengchang He, Shaoxian Shen, Yuyao Yi, et al.
Journal of Orthopaedic Surgery and Research
|
May 25, 2023
CPEB2 enhances cell growth and angiogenesis by upregulating ARPC5 mRNA stability in multiple myeloma
Piaorong Zeng, Fujue Wang, Xingxing Long, et al.
Frontiers in Pharmacology
|
February 8, 2024
Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)
Yiwen Bao, Jiaju Chen, Luting Duan, et al.
Page
of 3